CannaRoyalty Corp Receives a Buy from Canaccord Genuity

By Austin Angelo

CannaRoyalty Corp (CNQX: CRZ), the NA sector company, has received a rating update from a Wall Street analyst yesterday. The company received a Buy rating from Canaccord Genuity’s analyst Matt Bottomley, with a C$7.50 price target.

According to TipRanks.com, Bottomley is ranked #290 out of 4771 analysts.

CannaRoyalty Corp has an analyst consensus of Moderate Buy, with a price target consensus of C$7.50.

Based on CannaRoyalty Corp’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of C$843.6K and GAAP net loss of C$982.2K. In comparison, last year the company earned revenue of C$227.5K and had a GAAP net loss of C$1.54 million.

CannaRoyalty Corp. is an integrator and operation services in the field of legal cannabis in the United States, Canada, and Puerto Rico. It serves as a platform of holdings via royalty agreements, equity interests, secured convertible debt, and licensing agreements.